Your session is about to expire
← Back to Search
Focused Radiation vs Systemic Therapy for Kidney Cancer
Study Summary
This trial compares a new radiotherapy approach to usual care to see if it can improve outcomes in metastatic kidney cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants are being administered treatment as part of this experiment?
"This clinical trial mandates that 472 individuals with the appropriate inclusion criteria sign up for participation. Decatur Memorial Hospital in Chicago, Illinois and Northwestern University in Springfield, Missouri are two of many participating sites."
What risks do participants in Arm II (SAbR, usual care) face?
"Through our analysis, Arm II (SAbR, usual care) earned a 3 on the safety scale as it is in phase 3 testing and has multiple datasets corroborating its efficacy."
To what extent are there medical facilities carrying out this research trial in the state?
"This clinical trial is available at Decatur Memorial Hospital in Chicago, Iowa, Northwestern University in Springfield, Missouri and Southern Illinois University School of Medicine in Ames. An additional ten sites are also taking part."
Is enrollment currently available for this research project?
"Affirmative. Information present on clinicaltrials.gov indicates that this study is currently seeking participants, which was first advertised on September 7th 2023 and recently modified on October 13th 2023. 472 individuals need to be recruited from 10 distinct medical sites."
Share this study with friends
Copy Link
Messenger